• Home
  • Mutual Funds
  • ITI Pharma and Healthcare Fund Growth

ITI Pharma and Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

ITI Pharma and Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹500 & Lump. ₹5000

AUM (Fund size)

₹252 Cr

Lock In Period

N/A

Expense Ratio

2.66

Exit Load

If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50%.Exit Load after completion of 3 months - Nil.

Benchmark

NIFTY Healthcare Total Return Index

ITI Pharma and Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M5.33-0.537.93
6M13.871.6265.84
1Y3.633.66129.66
3Y18.4512.44242.05

Portfolio Analysis

  • Equity: 96.78%
  • Debt: 3.22%
  • Others
As on: 2026-06-30
View allocation % by

1. Sun Pharmaceutical Industries Limited13.34%
2. Divi's Laboratories Limited6.79%
3. Dr. Reddy's Laboratories Limited5.44%
4. Cipla Limited4.60%
5. Torrent Pharmaceuticals Limited4.56%
6. Laurus Labs Limited4.40%
7. Aurobindo Pharma Limited4.10%
8. Lupin Limited3.30%
9. Neuland Laboratories Limited3.09%
10. Cohance Lifesciences Limited2.89%
11. Mankind Pharma Limited2.84%
12. Alkem Laboratories Limited2.75%
13. Abbott India Limited1.82%
14. IPCA Laboratories Limited1.52%
15. Sai Life Sciences Limited1.30%
16. Shilpa Medicare Limited1.18%
17. Piramal Pharma Limited1.14%
18. Glenmark Pharmaceuticals Limited1.12%
19. Supriya Lifescience Limited1.03%
20. Biocon Limited0.97%
21. GlaxoSmithKline Pharmaceuticals Limited0.90%
22. Zydus Lifesciences Limited0.74%
23. Caplin Point Laboratories Limited0.59%
24. Syngene International Limited0.39%

1. Apollo Hospitals Enterprise Limited6.22%
2. Max Healthcare Institute Limited5.41%
3. Fortis Healthcare Limited2.94%
4. Global Health Limited2.01%
5. Aster DM Healthcare Limited1.54%
6. Healthcare Global Enterprises Limited1.09%
7. Rainbow Childrens Medicare Limited1.02%

1. Poly Medicure Limited1.28%

1. Linde India Limited1.25%

1. Shaily Engineering Plastics Limited1.22%

About Fund ITI Pharma and Healthcare Fund Growth

ITI Pharma and Healthcare Fund Growth managed by ITI Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹252 Crore. The fund benchmarks its performance against the NIFTY Healthcare Total Return Index while maintaining an expense ratio of 2.66. Under the expert guidance of Animesh Singh ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Animesh Singh

Mr. Animesh Singh holds Post Graduate Diploma in Management, Bachelor of Honours -(Economics) CFA - USA Certification. Prior to joining the ITI AMC, he was associated with Julius Baer wealth Advisor, Centrum Wealth, Nippon Life India Asset Management Ltd, Reliance Portfolio Management Services, KSBL and SSKI Securities.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
Quant Business Cycle Fund Growth01,015 CR2.85
Quant Quantamental Fund Growth21,652 CR2.79
ITI Pharma and Healthcare Fund Growth0251 CR2.66
HDFC Defence Fund Growth510,529 CR1.8
Nippon India Taiwan Equity Fund Growth31,191 CR2.6
Fund Name1Y3Y
This FundQuant Business Cycle Fund Growth2.726255.8177
This FundQuant Quantamental Fund Growth10.766662.1478
This FundITI Pharma and Healthcare Fund Growth3.626366.1846
This FundHDFC Defence Fund Growth18.3039173.2074
This FundNippon India Taiwan Equity Fund Growth126.5477228.1783

ITI Pharma and Healthcare Fund Growth FAQs

ITI Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of ITI Pharma and Healthcare Fund Growth is 2.66. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

ITI Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 5.33%
  • 6 Months : 13.87%
  • 1 Year : 3.63%
  • 3 Years : 18.45%
Returns of ITI Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ 17.6754 as on Jul 20,2026. Since inception, the return has been 66.18%.

You can invest in ITI Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of ITI Pharma and Healthcare Fund Growth is ₹252 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in ITI Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.